Navigation Links
MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial

ng (T2)) cranial MRI lesions (the primary endpoint of the trial) and other MRI-related, exacerbation and disability-related endpoints (relapse rate and Expanded Disability Status Scale (EDSS) score) after 12 months of treatment. Eligible patients who elected to continue their participation in the trial after 12 months of treatment will continue to receive treatment and will be assessed at months 13, 14, 16, 18, 20, 22 and 24 of the trial; patients who received placebo during the first 12 months of the trial were randomized to receive either 30 or 60 mg of MN-166 per day (double-blind maintained) during the second 12 months of the trial.

About Multiple Sclerosis and MN-166

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS), affecting approximately 250,000 - 350,000 people in the U.S. The most obvious effect of MS is the progressive loss of muscle control, but multiple brain and CNS functions are also affected. There is no cure for the disease. Relapsing-remitting MS (RRMS), which is the most common type of the disease, affects approximately 65% of MS patients according to a Cognos study published by Decision Resources, Inc. Most patients with RRMS eventually progress to the secondary progressive (SPMS) form of the disease.

MN-166 is a novel, orally administered compound being evaluated for the treatment of MS. MN-166 inhibits leukotriene activity, phosphodiesterases and nitric oxide synthase, all inflammatory mechanisms known to be involved in MS. MN-166 may also suppress the production of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and may enhance the production of the anti-inflammatory cytokines (IL-4, IL-10). In two pilot clinical trials sponsored by academic investigators in Japan, MN-166 was found to have certain beneficial effects with respect to the treatment of MS.

MediciNova acquired an exclusive, worldwide (excluding Japan, China, Taiwan and South Korea), sublicensable licens
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/1/2015)... Research and ... of the "2015 New Frontiers in ... Challenges, Emerging Technologies, Competitive Landscape" report ... Frontiers in European Clinical Chemistry and Immunodiagnostic ... is a new five-country strategic analysis of ...
(Date:7/1/2015)... , July 1, 2015  Echo Therapeutics, ... company focused on non-invasive continuous glucose monitoring and ... new and completely re-designed corporate website echotx.com ... access to Echo,s technology and enhances the quality ... new website better communicates to prospective customers and ...
(Date:7/1/2015)... -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), ... systems, announced today that its debt agreement with OrbiMed ... amendment removed a covenant that required Unilife to generate ... during the six months ended June 30, 2015. There ... of the debt agreement as part of this amendment. ...
Breaking Medicine Technology:2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3
... Inc. (OTC/BB: TBIO) today announced the ... to aid physicians in the diagnosis of mitochondrial disorders. ... identify mutations in more than 400 genes, and represents ... The announcement was made at the 2011 United Mitochondrial ...
... YORK, June 16, 2011 Reportlinker.com announces that ... its catalogue: UK CT Systems ... http://www.reportlinker.com/p0555197/UK-CT-Systems-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging Short Description ... market data on the CT systems in UK. ...
Cached Medicine Technology:Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting 2Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting 3Reportlinker Adds UK CT Systems - Market Trend Till 2016 2
(Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, ... that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held ... In addition to supporting S4L in its mission to provide free quality orthodontic ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... The ... from the New York Community Trust. The grant will allow CCF to improve quality ... proven practices. , CCF was formed to respond to many changes in New York’s ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... Lora Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales ... Conference in Phoenix, AZ. LTEN brings together learning and development professionals from more ...
(Date:7/1/2015)... ... 2015 , ... As if mood swings, cramps and child labor weren’t enough ... leg pain. Northeast Houston Vein Center is offering tips on the treatment options for ... is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, cramps ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. ... newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the ... is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... ... Thanks to an ever aging population, science and medicine are combining ... to combat what some believe is a genetically predisposed aging process in ... aging, longevity practices for diet, exercise, appearance and methods to improve overall ...
... ... until now, was popularly known as motivational words which is also known to some as, ... ... Akande speaking at the launching of his newly published book in London, UK on Thursday, ...
... ... ... annual "Top Doctors" issue, Westchester magazine included Dr. John Stangel as a lead fertility ... Medical Director of Reproductive Medicine Associates of Connecticut (RMACT) and has his office in Rye, ...
... ... TeezITNow.com will be focusing on the importance of family communications and promoting the value of ... ... safe sex should be top priority for parents this holiday season, according to Robert Moore, ...
... detection and treatment, study says , SUNDAY, Dec. 13 ... of cancer in everyday blood samples taken from patients, ... up biomarkers for prostate and breast cancers. Study co-author ... Nanoscience and Quantum Engineering in New Haven, Conn., said ...
... for coping with common scenarios , SATURDAY, Dec. 12 ... times, dysfunctional families and countless other factors, the holidays ... But there are ways to cope with the various ... according to Dr. Laura Miller, director of women,s mental ...
Cached Medicine News:Health News:Launch of ImmortalHumans.com as a Result of Humankind's Drive to Cure Aging and Become Biologically Immortal Within this Century 2Health News:Encouragement Words Takes on a New Terminology as Myeexpert Gifts Books, and Offers Free Counselling 2Health News:RMA of CT Doctor Named One of Westchester Magazine's 'Best MDs' 2Health News:RMA of CT Doctor Named One of Westchester Magazine's 'Best MDs' 3Health News:This Holiday Season Give Your Children the Gift that Saves Lives: Safer Sex 2Health News:'Nanosensors' Spot Early Signs of Cancer 2Health News:How to Attack Holiday Stress Head-On 2
Industry leader in the design and manufacturing of GP Lenses. Abba holds the CLMA seal of excellence award....
... data collection and management ... multiple store environment. Home ... office with the stores ... and inventory reporting, recalls ...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... SDS Octoplus Ordering/Dispensing has gained recognition as ... lens ordering system. It enables opticians to ... using SDS electronic communications technology. When used ... or 3D frame tracers, lens shapes are ...
Medicine Products: